Scandinavian Journal of Immunology · 2005 · 13 citations · 27 references
MedicineHematologyImmunologyClinical ImmunologyStem Cell TransplantationTransplant ImmunologyB-cell ResponsesConditioning RegimensHistocompatibilityImmune ReconstitutionImmune Repertoire FormationReduced-intensity ConditioningAllogeneic Stem Cell TherapyB Cell RecoveryConditioning Regimen IntensityImmune Reconstitution After Stem Cell TransplantationImmune Reconstitution After TransplantationLymphocyte ReconstitutionPost-transplant Cytomegalovirus Infection
The objective of this study was to investigate B-lymphocyte reconstitution in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) after myeloablative conditioning (MAC) or reduced-intensity conditioning (RIC) regimens. B-lymphocyte reconstitution was studied by monitoring the CDR3 repertoire with spectratyping. We demonstrate a delay in the recovery of the B-lymphocyte repertoire, measured by variation in size distribution of the immunoglobulin H CDR3 in patients conditioned with RIC compared to MAC. We found no general explanation for this finding, but when clinical data for each patient were studied in detail, we could identify a cause for the oligoclonality of the B-lymphocyte repertoire after HSCT with RIC for each of the patients. Older patients and donors, low cell dose at transplantation, relapse, graft-versus-host disease (GVHD) and its treatment as well as cytomegalovirus infection and its treatment are all possible causes for the restriction of the B-lymphocyte repertoire observed in this study. Taken together, reconstitution of the B-lymphocyte repertoire after HSCT is a process dependent on multiple factors and differs between patients. The conditioning regimen may be of importance, but data from this study suggest that individual factors and the various complications occurring after HSCT are more likely to determine the development of the B-lymphocyte repertoire.
27
Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.9K citations · Full text
Medicine, Hematology, Oncology +17
Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.8K citations
Medicine, Hematology, Oncology +17
Rainer Storb, H. Joachim Deeg, M. S. Pepe et al. · Blood · 1989 · 432 citations · Full text
Olle Ringdén, Tapani Ruutu, Mats Remberger et al. · Blood · 1994 · 340 citations · Full text
Medicine, Hematology, Oncology +15
Michael Boeckh, Rachel A. Carter, Brenda M. Sandmaier et al. · Blood · 2002 · 241 citations · Full text